For a drug to be approved for the pregnant population, it must go through rigorous testing with that population, and that has not yet happened for semaglutide or other GLP-1 (glucagon-like peptide 1) agonists, says Carrie Burns , MD, a board-certified endocrinologist and director of diabetes in pregnancy at Penn Medicine in Philadelphia
Rotate your injection sites To avoid soreness or irritation, switch between areas like: Abdomen (most common) Outer thigh Upper arm (if someone else is injecting) Keep a note of where youve injected each week
Their dual mechanisms of action, targeting appetite regulation and metabolic function, have made them promising options for those seeking not only glycemic control but also meaningful and sustainable weight reduction
Weight Loss Success Leads to High Demand Though the Food and Drug Administration (FDA) approved Ozempic to treat type II diabetes in 2017, its off-label side effect targeting the appetite hormone has made it popular for those trying to lose weight
